Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zifanocycline by KBP Biosciences for Skin And Skin Structure Infections (SSSI) Caused By Bacteria: Likelihood of Approval
Zifanocycline is under clinical development by KBP Biosciences and currently in Phase I for Skin And Skin Structure Infections (SSSI)...
Zifanocycline by KBP Biosciences for Community-Acquired Bacterial Pneumonia: Likelihood of Approval
Zifanocycline is under clinical development by KBP Biosciences and currently in Phase I for Community-Acquired Bacterial Pneumonia. According to GlobalData,...
Zifanocycline by KBP Biosciences for Acinetobacter Infections: Likelihood of Approval
Zifanocycline is under clinical development by KBP Biosciences and currently in Phase I for Acinetobacter Infections. According to GlobalData, Phase...